Physician profile
Amit Goyal
NPI 1598183014
$10,915.81
in general payments reported to CMS, 2019-2025
18 companies · $1,642 in 2025
The $1,642 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $1,105 · 2021: $646 · 2022: $549 · 2023: $2,815 · 2024: $3,958 · 2025: $1,642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,994 · Food and Beverage: $3,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,993.74 |
| Food and Beverage | $3,420.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,598.64 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,602.12 | 2022-2024 | Ultreon, Mitraclip, Optis |
| Boston Scientific Corporation | $1,653.13 | 2020-2022 | |
| Medtronic, INC. | $593.26 | 2023-2024 | Onyx Frontier, Corevalve Evolut R, Telescope |
| Abiomed | $335.38 | 2022-2025 | Impella |
| Globus Medical, INC. | $200.85 | 2019 | |
| Terumo Medical Corporation | $191.88 | 2021-2023 | Glidesheath Slender |
| Novo Nordisk INC | $144.63 | 2023 | Ozempic |
| Novartis Pharmaceuticals Corporation | $137.62 | 2022 | |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Shockwave Medical, INC | $117.33 | 2021 | |
| Amgen INC. | $65.86 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $43.84 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.54 | 2021-2023 | Lifevest |
| Lemaitre Vascular, INC. | $30.00 | 2025 | Artegraft Vascular Graft |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $20.98 | 2022 | |
| Pfizer INC. | $20.41 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.